Pristiq vs. Viibryd
See how Pristiq and Viibryd compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Pristiq and Viibryd are both FDA-approved for major depressive disorder in adults but work differently: Pristiq is an SNRI, while Viibryd is a serotonin partial agonist and reuptake inhibitor.
Pristiq starts and stays at a fixed 50 mg dose with no titration, while Viibryd requires a two-week dose increase and must be taken with food to absorb properly.
Pristiq's most common side effects are nausea and dry mouth, while Viibryd's are dominated by gastrointestinal issues like diarrhea and nausea.
Pristiq vs. Viibryd Drug Summary
Pristiq
Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat major depressive disorder in adults. It's taken once daily as an extended-release tablet, and the 50 mg starting dose is also the full therapeutic dose, so no titration is typically needed.
Viibryd
Viibryd (vilazodone) is a serotonin partial agonist and reuptake inhibitor (SPARI) approved to treat major depressive disorder in adults. It's taken once daily with food, starting at a lower dose and increasing over two weeks to reach the 40 mg maintenance dose.
Pristiq vs. Viibryd Side Effects
Pristiq
Viibryd
Pristiq vs. Viibryd Dosage
Pristiq
Viibryd
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg once daily | At the start |
| Maximum dose | 50 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Days 1-7 |
| Maximum dose | 40 mg once daily | Day 15 onward |
| Dose changes | 2 increases | Every 7 days |
Pristiq
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg once daily | At the start |
| Maximum dose | 50 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Viibryd
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Days 1-7 |
| Maximum dose | 40 mg once daily | Day 15 onward |
| Dose changes | 2 increases | Every 7 days |
Pristiq vs. Viibryd Indications
Pristiq
Pristiq is FDA-approved only for major depressive disorder in adults. It has not been studied for pediatric use, and people with significant kidney impairment need a lower dose.
Major depressive disorder (MDD) in adults
Not approved for pediatric patients
Requires dose adjustment in end-stage renal disease
Once-daily oral extended-release tablet
Viibryd
Viibryd is FDA-approved only for major depressive disorder in adults, the same single indication as Pristiq. It is not approved for pediatric MDD, and its absorption depends heavily on taking it with food.
Major depressive disorder (MDD) in adults
Not approved for pediatric MDD
Must be taken with food for proper absorption
Once-daily oral tablet
Pristiq vs. Viibryd Pros and Cons
Pristiq
Pristiq's biggest practical advantage is simplicity: there's no titration schedule, and the 50 mg starting dose is also the full therapeutic dose. Generic desvenlafaxine is available, though nausea, dry mouth, and other side effects are relatively common.
Pros
No titration schedule needed before reaching the therapeutic dose
Can be taken with or without food
Generic desvenlafaxine offers cost savings over brand
Cons
Nausea and dry mouth are common, affecting a large share of users
Requires dose adjustment in significant kidney impairment
Higher doses showed no added benefit, limiting dose flexibility
Viibryd
Viibryd's mechanism, partial 5-HT1A receptor agonism plus reuptake inhibition, gives it a distinct profile from typical SSRIs and SNRIs like Pristiq. It requires a two-week titration and must be taken with food, and it has no widely available generic despite FDA generic approval.
Pros
Distinct partial-agonist mechanism may help those who haven't responded to SSRIs/SNRIs
Gradual two-week titration may ease early tolerability
Lower reported rate of dry mouth than Pristiq (up to 5% vs up to 25%)
Cons
Must be taken with food or absorption drops significantly
No widely available generic despite FDA generic approval
Requires a two-week titration before reaching the full dose
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.